PBT assessment
-
REACH
- Κατανόηση του REACH
- Προσδιορισμός ουσιών
- Kαταχώριση
- Αξιολόγηση
- Αδειοδότηση
- Περιορισμός
- Επικοινωνία στην αλυσίδα εφοδιασμο
- Υποψήφιες ουσίες σε αντικείμενα
- Νομοθεσία
- Δοκιμές σε ζώα στο πλαίσιο του κανονισμού REACH
- Εφαρμογή της νομοθεσίας
- Νανοϋλικά
- Αξιολόγηση των κανονιστικών αναγκών
- PBT assessment
- Endocrine disruptor assessment
-
Cooperation with authorities and stakeholders
- RIME+ Platform
- Ομάδα εμπειρογνωμόνων για τις ανθεκτικές, βιοσυσσωρεύσιμες και τοξικές ουσίες (ΑΒΤ)
- Ομάδα εμπειρογνωμόνων για τους ενδοκρινικούς διαταράκτες
- REACH Exposure Expert Group
- Ομάδα εργασίας PETCO
- Plastic additives initiative
- Metals and Inorganics Sectoral Approach
- ECHA-CEFIC collaboration on dossier compliance
- Ουσίες που πιθανώς να προκαλέσουν ανησυχία
PBT assessment
Annex XIII to the REACH Regulation sets criteria for substances that are persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB).
Under REACH, a PBT/vPvB assessment is required for all substances for which a chemical safety assessment is carried out. A chemical safety assessment is required for substances manufactured or imported in amounts of 10 tonnes or more per year, unless exemptions apply.
All biocidal active substances have to undergo a formal PBT assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.
The PBT Expert Group supports Member States in their assessments. The substances undergoing a PBT/vPvB assessment under REACH or the Biocidal Products Regulation that have been brought for discussion to ECHA’s PBT Expert Group are included in the PBT assessment list.
The PBT/vPvB concern
Substances that persist for long periods of time in the environment and have a high potential to accumulate in biota are of specific concern because their long-term effects are rarely predictable. Once they have entered the environment, exposure to these substances is very difficult to reverse, even if emissions are stopped.
Protection of pristine remote areas from PBT/vPvB substances is particularly difficult, as these substances do not degrade near emission sources but may be gradually transported into remote areas. A ‘safe’ concentration in the environment cannot be established using the methods currently available.
A particular concern with vPvB substances is that even if no adverse effects can be demonstrated under laboratory testing conditions, long-term effects might be possible, as high but unpredictable levels may be reached in humans or the environment over extended time periods.